Intravenous MAGnesium Efficacy in Stroke "IMAGES"

Completed

Phase 3 Results

Summary of Purpose

To assess the possible neuroprotective efficacy of intravenous magnesium sulfate administered within 12 hours of acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 May 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • UK Medical Research Council.

Trial Design

Multicenter, double-blind, randomized placebo-controlled trial.

Contacts

Not available